Does ZUCLOPENTHIXOL Cause Tonsillar hypertrophy? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Tonsillar hypertrophy have been filed in association with ZUCLOPENTHIXOL. This represents 0.6% of all adverse event reports for ZUCLOPENTHIXOL.
14
Reports of Tonsillar hypertrophy with ZUCLOPENTHIXOL
0.6%
of all ZUCLOPENTHIXOL reports
14
Deaths
14
Hospitalizations
How Dangerous Is Tonsillar hypertrophy From ZUCLOPENTHIXOL?
Of the 14 reports, 14 (100.0%) resulted in death, 14 (100.0%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Tonsillar hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZUCLOPENTHIXOL. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ZUCLOPENTHIXOL Cause?
Drug ineffective (660)
Dyskinesia (414)
Schizophrenia (409)
Dystonia (404)
Sedation (403)
Sexual dysfunction (394)
Suicide attempt (389)
Blood glucose increased (379)
Anosognosia (374)
Blood prolactin abnormal (374)
What Other Drugs Cause Tonsillar hypertrophy?
ADALIMUMAB (151)
ONDANSETRON (51)
SOMATROPIN (43)
SECUKINUMAB (42)
DUPILUMAB (39)
METHOTREXATE (39)
INFLIXIMAB (31)
TACROLIMUS (26)
INFLIXIMAB-DYYB (25)
ETANERCEPT (24)
Which ZUCLOPENTHIXOL Alternatives Have Lower Tonsillar hypertrophy Risk?
ZUCLOPENTHIXOL vs ZUCLOPENTHIXOL DECANOATE
ZUCLOPENTHIXOL vs ZURANOLONE
ZUCLOPENTHIXOL vs ZYPREXA
ZUCLOPENTHIXOL vs ZYTIGA
ZUCLOPENTHIXOL vs ZYVOX